Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
583.01
-15.75 (-2.63%)
At close: May 01, 2025, 3:03 PM
Regeneron Pharmaceuticals Revenue
Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending March 31, 2025, Regeneron Pharmaceuticals generated $3.03B in revenue.
Revenue (ttm)
$14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
$940.16K
Employees
15,106
Market Cap
62.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.2B | +8.27% |
| Dec 31, 2023 | 13.12B | +7.76% |
| Dec 31, 2022 | 12.17B | -24.26% |
| Dec 31, 2021 | 16.07B | +89.14% |
| Dec 31, 2020 | 8.5B | n/a |